Camson Bio Technologies Ltd Quarterly Results

Gross Sales

46.17

63.51

47.1

46.24

39.49

Excise Duty

0

0

0

0

0

Net Sales

46.17

63.51

47.1

46.24

39.49

Other Operating Income

0

0

0

0

0

Other Income

5.9

0.35

0.15

0.02

0.04

Total Income

52.07

63.86

47.25

46.26

39.54

Total Expenditure

50.85

55.99

42.39

39.04

30.3

PBIDT

1.22

7.88

4.86

7.22

9.24

Interest

2.08

1.02

0.84

1.15

1.22

PBDT

-0.86

6.85

4.02

6.07

8.02

Depreciation

3.79

3.51

3.36

3.34

1.35

Minority Interest Before NP

0

0

0

0

0

Tax

0.87

1.9

0.44

-1.23

-1.36

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-5.52

1.45

0.22

3.96

8.04

Minority Interest After NP

-1.46

-0.3

-0.01

-0.05

-0.02

Net Profit after Minority Interest

-4.06

1.75

0.23

4.01

8.05

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-4.06

1.75

0.23

4.01

8.05

EPS (Unit Curr.)

-1.41

0.58

0.08

1.41

2.68

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

30

30

30

28.33

25.23

Public Shareholding (Number)

2,26,61,240

2,26,61,240

2,26,61,240

2,09,86,912

1,85,86,912

Public Shareholding (%)

75.54

75.54

75.54

74.09

73.68

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

73,38,600

73,38,600

73,38,600

73,38,600

66,38,600

Non Encumbered - % in Total Promoters Holding

100

100

100

100

100

Non Encumbered - % in Total Equity

24.46

24.46

24.46

25.91

26.32

PBIDTM(%)

2.64

12.4

10.31

15.61

23.39

PBDTM(%)

-1.86

10.78

8.53

13.12

20.3

PATM(%)

-11.95

2.28

0.46

8.56

20.35